Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2009
08/13/2009CA2712080A1 Breaking immunological tolerance with a genetically encoded unnatural amino acid
08/12/2009EP2088197A2 Haemophilus influenzae antigens and corresponding DNA fragments
08/12/2009EP2088159A1 Antibody recognizing c-domain of midkine
08/12/2009EP2088149A1 Pharmacologically active n,n'-substituted 3,7-diazabicyclo ý3.3.1¨nonanes, pharmaceutical compositions based thereon and a method for the use thereof
08/12/2009EP2087900A1 Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antogonist terpenic fraction, and compostions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders
08/12/2009EP2087893A1 Compositions comprising alprazolam for treating primary insomnia and insomnia associated with anxiety states and processes for preparing them
08/12/2009EP2087892A2 (S,S) reboxetine for treating age associated learning and mental disorders
08/12/2009EP2087891A2 Pharmaceutical compositions for treating lymphoma
08/12/2009EP2087885A1 Use of urokinase inhibitors for the treatment and /or prevention of neuropathological diseases
08/12/2009EP2086978A1 Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5-a]pyrimidin-7-yl]-phenyl-n-methyl-acetamide
08/12/2009EP2086960A1 Novel inhibitors of glutaminyl cyclase
08/12/2009EP2086959A1 Substituted 2-imidazoles as modulators of the trace amine associated receptors
08/12/2009EP2086958A2 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
08/12/2009EP2086933A2 Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
08/12/2009EP2086643A1 Compounds which potentiate ampa receptor and uses thereof in medicine
08/12/2009EP2086558A2 Ph 1b toxin, cdna of ph 1 b toxin gene, pharmaceutical compositions containing ph 1b toxin, processes for their obtention and product
08/12/2009EP2086547A2 Solid forms of (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of their use
08/12/2009EP2086541A2 Compositions for reducing nicotine withdrawal symptoms and/or tobacco usage
08/12/2009EP2086539A1 Selective glycosidase inhibitors
08/12/2009EP2086538A2 Combination therapies for treating alzheimer's disease using i.a. dimebon and dolepezil
08/12/2009EP2086536A1 The use of pramipexole or a salt thereof for the treatment of parkinson's disease
08/12/2009EP2086527A2 Systems for effecting cessation of tobacco use
08/12/2009EP2086508A2 Cationic colloidal carriers for delivery of active agents to the blood-brain barrier in the course of neuroinflammatory diseases
08/12/2009EP2086328A2 Novel arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
08/12/2009EP2086317A2 Nicotine formulations, kits and systems and methods for their use
08/12/2009EP1949906A4 Agent for correcting stress-inducing neuro-mediator, neuro- endocrine and metabolic disturbances and method for preventing and treating concomitant pathological conditions
08/12/2009EP1904493A4 Tetrahydroprotoberberine compounds, the synthetic method and the use thereof
08/12/2009EP1896588B1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF
08/12/2009EP1888094B1 Amylin and amylin agonists for treating psychiatric diseases and disorders
08/12/2009EP1636221B1 3-Heterocyclyl-Azetidine compounds useful as NK1/NK2 receptors antagonists
08/12/2009EP1567150B1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
08/12/2009EP1515959B1 Pharmaceutical salts of reboxetine
08/12/2009EP1463735B1 Imidazo¬2,1-b -1,3,4-thiadiazole sulfonamides
08/12/2009EP1429771B1 Bicyclic compounds as inhibitors of chemokine binding to us28
08/12/2009EP1416048B1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant
08/12/2009EP1409645B1 Probiotic lactobacillus salivarius strains
08/12/2009EP1385514B9 Spiroindene and spiroindane compounds
08/12/2009EP1379257B1 Prodrugs of anticancer agents employing substituted aromatic acids
08/12/2009EP1343760B1 Muscarinic antagonists
08/12/2009EP1290227B1 Compositions, kits, and methods for identification and modulation of type i diabetes
08/12/2009EP1255813B1 Multipotent neural stem cells from mammalian skin and uses thereof
08/12/2009EP1242105B3 Combination of ginseng and ginkgo to improve cognitive skills
08/12/2009CN101506236A Monoclonal antibodies against amyloid beta protein and uses thereof
08/12/2009CN101506225A Cardioprotective compounds
08/12/2009CN101506215A Adenosine A2a receptor antagonists
08/12/2009CN101506213A Amino- imidazolones and their use as a medicament for treating cognitive impairment. alzheimer disease, neurodegeneration and dementia.
08/12/2009CN101506212A Amino- imidazolones and their use as a medicament for treating cognitive impairment. alzheimer disease, neurodegeneration and dementia.
08/12/2009CN101506202A mGluR5 modulators I
08/12/2009CN101506201A Novel heteroaryl substituted benzoxazoles
08/12/2009CN101506199A Azetidine compounds as orexin receptor antagonists
08/12/2009CN101506172A Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2 -methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine
08/12/2009CN101506169A Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate
08/12/2009CN101506164A Piperidine derivatives
08/12/2009CN101506162A Substituted isoindoles as bace inhibitors and their use
08/12/2009CN101506157A Co-crystals of pyrrolidinones
08/12/2009CN101506156A Pyrrolidine derivatives having activity at the GlyT1 transporter
08/12/2009CN101505788A Prophylactic and/or therapeutic agents for peripheral neuropathy
08/12/2009CN101505741A A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation
08/12/2009CN101505739A Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
08/12/2009CN101505732A Low dose sublingual tablets of opioid analgesics and preparation process
08/12/2009CN101503414A Thiazolo[3,2-b]-1,2,4-triazine derivative and use thereof
08/12/2009CN101503386A Method for refining 1-amyl-3-(4-methyl-1-naphthoyl) indole
08/12/2009CN101503365A Preparation of venlafaxine intermediate 1-[2-amino-1-(4-methoxy phenyl)ethyl] cyclohexanol
08/12/2009CN101503341A Novel technique for preparing schizandrol A and schizandrol B
08/12/2009CN101502643A Applications of hCRF and derivatives thereof in preparing medicament for treating Guillain Barre syndrome
08/12/2009CN101502622A External-use medicament composition for treating indigestion as well as preparation method and application thereof
08/12/2009CN101502613A Body-strengthening fatigue-resisting lipid-lowering oral liquid and capsule
08/12/2009CN101502612A Kidney-tonifying essence-enriching brain-tonifying pill
08/12/2009CN101502610A Method for extracting veratrum alkaloid from Veratrum nigrum by supercritical carbon dioxide
08/12/2009CN101502601A Chinese medicinal composition for Alzheimer's symptoms and preparation method thereof
08/12/2009CN101502596A Medicicament for giving up smoking
08/12/2009CN101502592A Medicament for treating neurasthenia
08/12/2009CN101502585A Chinese red pepper plant extract as well as preparation method and application thereof
08/12/2009CN101502547A Application of notoginseng extract in preparing medicament for preventing and treating parkinsonism
08/12/2009CN101502546A Ginseng (root) oligosacchride preparation and novel use thereof
08/12/2009CN101502519A Novel use of vitamin B6 and folic acid namely effects of the two medicaments used together for tranquilizing, hypnotizing and strengthening abirritation
08/12/2009CN101502507A Egonol type benzofuran and novel use in pharmacy of glycosides thereof
08/12/2009CN101502500A Pressurised metered dose inhalers containing solutions of beta-2 agonists
08/12/2009CN101502324A Kava pepper extract effervescent tablet and technique for preparing the same
08/12/2009CN100526314C Production of high-purity corydalis
08/12/2009CN100526308C Arylvinylazacycloalkane compounds and methods of preparation and use thereof
08/12/2009CN100526307C Metalloproteinase inhibitors
08/12/2009CN100526305C Compound for promoting neurocyte growth
08/12/2009CN100525831C Improved pharmaceutical botulinum toxin compositions
08/12/2009CN100525815C A medicinal wine capable of treating multiple diseases
08/12/2009CN100525809C Medicinal composition of milkvetch root, chinaroot greenbrier and Hong Jingtian and its making method
08/12/2009CN100525785C Medicine for treating neuralgia, and its preparation method
08/12/2009CN100525768C Novel compounds
08/12/2009CN100525765C Lappaconitine hydrobromide dispersible tablet and its preparing method
08/12/2009CN100525764C Use of pyrazolopyridines for the treatment of cognitive deficits
08/12/2009CN100525763C Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
08/12/2009CN100525761C Pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
08/12/2009CN100525760C Duloxetine hydrochloride sustained release medicine
08/11/2009US7572913 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine
08/11/2009US7572888 Fusion protein comprising arrestin and green fluorescent protein for use in identifying ligands for g-protein coupled receptors
08/11/2009US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
08/11/2009US7572883 Somatostatin-dopamine chimeric analogs
08/11/2009US7572833 E.g., N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal stabilized with a lipid; improved absorption and penetration; treating ischemia, immune diseases, Alzheimer's disease, osteoporosis, brain disorders, eye diseases, osteoporosis
08/11/2009US7572822 Biaryl substituted triazoles as sodium channel blockers
08/11/2009US7572815 Amide derivative
1 ... 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 ... 1833